# Testing a Novel Therapeutic Strategy for Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder

> **NCT05692271** · PHASE2 · UNKNOWN · sponsor: **Centre for Addiction and Mental Health** · enrollment: 48 (estimated)

## Conditions studied

- Stress Disorders, Post-Traumatic
- Alcohol Use Disorder

## Interventions

- **DRUG:** Propranolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05692271
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-15
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05692271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05692271, "Testing a Novel Therapeutic Strategy for Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05692271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*